BIOGEN SAYS PARTNER EISAI PLANS TO FILE FOR TRADITIONAL APPROVAL OF ALZHEIMER'S DRUG IN U.S., EUROPE AND JAPAN AT END OF Q1 2023
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
194.4 USD | +2.03% | -1.92% | 27.69B | ||
- Stock Market
- Stock Market News in real time
- Economy
- Biogen Says Partner Eisai Plans To File For Traditional Approval…